Tbilisi, Republic of Georgia, and Pegasus Pharmaceuticals Group Inc., BC, Canada, March 28, 2010 --- Pegasus Pharmaceuticals Group Inc. today announced that the Agency of State Regulation of Medical Activity of the Ministry of Labour, Health and Social Affairs of Georgia has issued a new drug approval for HemoMex S™ Capsule of Dammarane Sapogenins 150 mg on March 22, 2010.

An OBET-based innovative solid disperse formulation HemoMex S™ Capsule of Dammarane Sapogenins 150 mg was approved as a prescription drug which can be used in combination with chemotherapeutic agents and/or radiotherapy for solid tumors, and used for the treatment of neutropenia complicated to chemotherapy and/or radiotherapy.